Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 15/20 | 0.56 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4024302 | 1.00 | HCRTR1 (0.56) | HCRTR1TAS1R3TAS1R1TAS1R2MEN1 | |
| SCHEMBL4020548 | 1.00 | HCRTR1 (0.56) | HCRTR1TAS1R3TAS1R1TAS1R2MEN1 | |
| SCHEMBL1660057 | 0.91 | HCRTR1 (0.54) | HCRTR1TAS1R3TAS1R1TAS1R2GAA | |
| SCHEMBL4019633 | 0.88 | HCRTR1 (0.54) | HCRTR1KDM4EPOLBGAA | |
| SCHEMBL4025408 | 0.87 | HCRTR1 (0.55) | HCRTR1MEN1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL2882365 | 0.87 | HCRTR1 (0.55) | HCRTR1 | |
| SCHEMBL2885994 | 0.87 | HCRTR1 (0.55) | HCRTR1 | |
| SCHEMBL2882368 | 0.87 | HCRTR1 (0.55) | HCRTR1 | |
| SCHEMBL16512784 | 0.86 | HCRTR1 (0.50) | HCRTR1TAS1R3TAS1R1TAS1R2KDM4E | |
| SCHEMBL17863662 | 0.86 | HCRTR1 (0.50) | HCRTR1TAS1R3TAS1R1TAS1R2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524968-B2 | 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides | BAYER CROPSCIENCE S.A. (FR) | 2009-04-28 | — | — | US | disclosed |
| US-20070203204-A1 | 2-Pyridinylcycloalkylbenzamide Derivatives And Their Use As Fungicides | BAYER CROPSCIENCE S.A. (FR) | 2007-08-30 | — | — | US | disclosed |
| CN-1946694-A | 2-Pyridylcycloalkylbenzamide derivatives and their use as fungicides | BAYER CROPSCIENCE SA (FR) | 2007-04-11 | — | — | CN | disclosed |
| EP-1740542-A1 | 2-PYRIDINYLCYCLOALKYLBENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2007-01-10 | — | — | EP | disclosed |
| WO-2005103004-A1 | 2-PYRIDINYLCYCLOALKYLBENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2005-11-03 | — | — | WO | disclosed |
| EP-1591442-A1 | 2-Pyridinycycloalkylbenzamide derivatives and their use as fungicides | Bayer CropScience S.A. (FR) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203204-A1 | 2-Pyridinylcycloalkylbenzamide Derivatives And Their Use As Fungicides | CYP1A2, CYP4B1, CYP1B1 | HCRTR1 4059/4885TAS1R3 1851/4885TAS1R1 1985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.